| Q28262129 | A single amino acid change in IFN-β1 abolishes its antiviral activity |
| Q35746183 | Antiviral activities of hybrids of two major human leukocyte interferons |
| Q36436383 | Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice |
| Q36248940 | Biologic activity in a fragment of recombinant human interferon alpha |
| Q35670501 | Constitutive, long-term production of human interferons by hamster cells containing multiple copies of a cloned interferon gene |
| Q38017932 | From cloning to a commercial realization: human alpha interferon |
| Q30412481 | High‐Performance Liquid Chromatography: Analytic and Preparative Applications in Protein‐Structure Determination |
| Q40076501 | Interferon Synthesis by Micro-organisms |
| Q41928595 | Interferon-omega: Current status in clinical applications |
| Q33237349 | Isolation and characterization of a novel interferon-α-encoding gene, IFN-α11 within a murine IFN cluster |
| Q33679491 | Mass spectrometric characterization of the isoforms in Escherichia coli recombinant DNA-derived interferon alpha-2b |
| Q40310717 | Molecular characterization and biological activity of bovine interferon-omega3. |
| Q70164690 | Multiple molecular forms of interferon display different specific activities in the induction of the antiviral state and 2'5' oligoadenylate synthetase |
| Q41501404 | New and atypical families of type I interferons in mammals: comparative functions, structures, and evolutionary relationships. |
| Q77364359 | Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery |
| Q72650571 | Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferon |
| Q72659435 | Possible conformation of interferons: A prediction based on amino acid composition and sequence |
| Q72674007 | Properties of a Human Alpha-Interferon Purified fromE. ColiExtracts |
| Q68231232 | Specificity of the immunoadsorbent used for large-scale recovery of interferon alpha-2a |
| Q72676155 | Structural features of human leukocyte interferon A as determined by circular dichroism spectroscopy* |
| Q44994392 | Structural model for interferons |
| Q36651271 | Structure and properties of human interferon-alpha from Namalwa lymphoblastoid cells |
| Q41046336 | The bovine IFN-omega 1 is biologically active and secreted at high levels in the yeast Pichia pastoris |
| Q41790336 | The cysteines in position 1 and 86 of rat interferon-alpha 1 are indispensable for antiviral activity |
| Q40106074 | The human interferons—From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyond |
| Q39506356 | The interferon genes |
| Q24300827 | The structure of eight distinct cloned human leukocyte interferon cDNAs |
| Q72680849 | The structure of human interferrons |
| Q30361968 | Therapeutic alpha-interferons protein: structure, production, and biosimilar. |
| Q24618084 | Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides |
| Q44828228 | Type I interferon genes from the egg-laying mammal, Tachyglossus aculeatus (short-beaked echidna). |
| Q27734359 | Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography |